Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001701541-25-000016
Filing Date
2025-03-06
Accepted
2025-03-06 16:03:32
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bdtx-20241231.htm   iXBRL 10-K 1749041
2 EX-19 bdtx-thirdarinsidertrading.htm EX-19 106276
3 EX-23.1 exhibit231_q42024.htm EX-23.1 2304
4 EX-31.1 exhibit311_q42024.htm EX-31.1 12398
5 EX-31.2 exhibit312_q42024.htm EX-31.2 11973
6 EX-32.1 exhibit321_q42024.htm EX-32.1 9436
12 GRAPHIC bdtx-20241231_g1.jpg GRAPHIC 76638
13 GRAPHIC bdtx-20241231_g2.jpg GRAPHIC 167154
14 GRAPHIC bdtx-20241231_g3.jpg GRAPHIC 189403
15 GRAPHIC bdtx-20241231_g4.jpg GRAPHIC 721302
  Complete submission text file 0001701541-25-000016.txt   10218086

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20241231.xsd EX-101.SCH 40950
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdtx-20241231_cal.xml EX-101.CAL 70110
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdtx-20241231_def.xml EX-101.DEF 154594
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20241231_lab.xml EX-101.LAB 635229
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20241231_pre.xml EX-101.PRE 420027
92 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20241231_htm.xml XML 818815
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39200 | Film No.: 25715146
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)